blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3397280

EP3397280 - PESTIVIRUS MARKER VACCINE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.02.2021
Database last updated on 16.11.2024
FormerExamination is in progress
Status updated on  09.04.2019
FormerRequest for examination was made
Status updated on  05.10.2018
FormerThe international publication has been made
Status updated on  07.07.2017
Formerunknown
Status updated on  24.01.2017
Most recent event   Tooltip12.02.2021Application deemed to be withdrawnpublished on 17.03.2021  [2021/11]
Applicant(s)For all designated states
Intervet International B.V.
Wim de Körverstraat 35
5831 AN Boxmeer / NL
[2018/45]
Inventor(s)01 / REIMANN, Ilona
Suedufer 10
17493 Greifswald-Insel Riems / DE
02 / KÖNIG, Patricia
Südufer 10
17493 Greifswald-Insel Riems / DE
03 / BEER, Martin
Suedufer 10
17493 Greifswald-Insel Riems / DE
 [2018/45]
Representative(s)Intervet International B.V.
Hertford Road
Hoddesdon, Hertfordshire EN11 9BU / GB
[2018/45]
Application number, filing date16826054.523.12.2016
[2018/45]
WO2016EP82537
Priority number, dateEP2015020320230.12.2015         Original published format: EP 15203202
[2018/45]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017114778
Date:06.07.2017
Language:EN
[2017/27]
Type: A1 Application with search report 
No.:EP3397280
Date:07.11.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 06.07.2017 takes the place of the publication of the European patent application.
[2018/45]
Search report(s)International search report - published on:EP06.07.2017
ClassificationIPC:A61K39/12, C07K14/005, C12N7/04
[2018/45]
CPC:
A61K39/12 (EP,US); A61P31/12 (EP); A61P31/14 (EP);
A61P37/04 (EP); C07K14/005 (EP,US); C12N7/04 (EP,US);
A61K2039/5252 (EP,US); A61K2039/5254 (US); A61K2039/55555 (EP,US);
A61K2039/575 (US); C07K2319/00 (EP,US); C12N2770/24321 (EP,US);
C12N2770/24322 (EP,US); C12N2770/24334 (EP,US); C12N2770/24362 (EP,US);
C12N2770/24371 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/45]
TitleGerman:PESTIVIRUSMARKERIMPFSTOFF[2018/45]
English:PESTIVIRUS MARKER VACCINE[2018/45]
French:VACCIN MARQUEUR DE PESTIVIRUS[2018/45]
Entry into regional phase30.07.2018National basic fee paid 
30.07.2018Designation fee(s) paid 
30.07.2018Examination fee paid 
Examination procedure01.06.2018Amendment by applicant (claims and/or description)
30.07.2018Examination requested  [2018/45]
30.07.2018Date on which the examining division has become responsible
12.04.2019Despatch of a communication from the examining division (Time limit: M04)
12.08.2019Reply to a communication from the examining division
06.04.2020Despatch of a communication from the examining division (Time limit: M06)
17.10.2020Application deemed to be withdrawn, date of legal effect  [2021/11]
06.11.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2021/11]
Fees paidRenewal fee
10.12.2018Renewal fee patent year 03
10.12.2019Renewal fee patent year 04
09.12.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]EP1174506  (STICHTING DIENST LANDBOUWKUNDI [NL]) [A] 1-21 * paragraph [0027] * * abstract ** figure 1 *;
 [A]WO2013027149  (AH USA 42 LLC [US], et al) [A] 1-21 * the whole document *;
 [AD]WO2014033149  (INTERVET INT BV [NL], et al) [AD] 1-21 * abstract * * page 5, line 15 - line 20 * * page 15, line 4 - line 35 *;
 [I]  - MEYER DENISE ET AL, "New insights into the antigenic structure of the glycoprotein Ernsof classical swine fever virus by epitope mapping", VIROLOGY, (20120804), vol. 433, no. 1, doi:10.1016/J.VIROL.2012.06.029, ISSN 0042-6822, pages 45 - 54, XP028938148 [I] 20 * abstract * * page 46, column l, paragraph l - column r, paragraph 2 * * figure 5 *

DOI:   http://dx.doi.org/10.1016/j.virol.2012.06.029
 [AD]  - YUGANG LUO ET AL, "Construction of chimeric bovine viral diarrhea viruses containing glycoprotein Erns of heterologous pestiviruses and evaluation of the chimeras as potential marker vaccines against BVDV", VACCINE, (20120601), vol. 30, no. 26, doi:10.1016/j.vaccine.2012.04.016, ISSN 0264-410X, pages 3843 - 3848, XP055044173 [AD] 1-21 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.vaccine.2012.04.016
 [AD]  - MARIA RICHTER ET AL, "Complementation studies with the novel Bungowannah virus provide new insights in the compatibility of pestivirus proteins", VIROLOGY, vol. 418, no. 2, doi:10.1016/J.VIROL.2011.07.014, ISSN 0042-6822, (20110722), pages 113 - 122, (20110727), XP028277426 [AD] 1-21 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.virol.2011.07.014
 [A]  - P.L. EBLÉ ET AL, "Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: Protection and DIVA characteristics", VETERINARY MICROBIOLOGY, (20130301), vol. 162, no. 2-4, doi:10.1016/j.vetmic.2012.10.030, ISSN 0378-1135, pages 437 - 446, XP055102685 [A] 1-21 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.vetmic.2012.10.030
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.